Telemetry Investments’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Telemetry Investments’s Portfolio FRTX Stock Details FRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$95K	Sell	65,000 -1,000	-2%	-$1.77K	0.15%	89
2022 Q3	$118K	Buy	66,000 +41,889	+174%	+$121K	0.15%	114
2022 Q2	$137K	Sell	24,111 -18,225	-43%	-$165K	0.16%	116
2022 Q1	$510K	Sell	42,336 -13,952	-25%	-$151K	0.8%	47
2021 Q4	$580K	Buy	56,288 +40,747	+262%	+$732K	0.75%	44
2021 Q3	$504K	Buy	15,541 +1,986	+15%	+$64.4K	0.68%	48
2021 Q2	$580K	Buy	13,555 +2,159	+19%	+$88.8K	0.8%	48
2021 Q1	$559K	Buy	11,396 +7,043	+162%	+$387K	0.63%	61
2020 Q4	$153K	Buy	+4,353	New	+$137K	0.26%	86

Other funds holding FRTX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 29.84% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Telemetry Investments's FRTX Position: Q4 2022 in Review

Telemetry Investments reduced its Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) stake by 1.5% in Q4 2022, selling an estimated $1.77K and leaving 65,000 shares worth $95K. The position accounts for 0.15% of the portfolio, ranked #89.

Telemetry Investments first reported a position in FRTX in Q4 2020 and has held it in 9 quarters since. The position peaked at $580K in Q4 2021. 16 funds tracked by Wall St. Rank hold FRTX as of Q4 2022.

Telemetry Investments held 65,000 shares of Fresh Tracks Therapeutics, Inc. Common Stock worth $95K as of Q4 2022.
Telemetry Investments sold 1,000 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $1.77K.
Fresh Tracks Therapeutics, Inc. Common Stock made up 0.15% of Telemetry Investments's portfolio in Q4 2022, its #89 holding.
Telemetry Investments first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q4 2020 and has held it in 9 quarters since.
Telemetry Investments's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $580K in Q4 2021.
16 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.